Disclaimer
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and the lives of patients worldwide.
1658
page-template-default,page,page-id-1658,bridge-core-1.0.6,,qode-theme-ver-18.2,qode-theme-bridge,disabled_footer_top,disabled_footer_bottom,qode_advanced_footer_responsive_1000,qode_header_in_grid,wpb-js-composer js-comp-ver-7.6,vc_responsive

Disclaimer

Disclaimer

The information contained in this website is for general information purposes only. Oculis’ drug candidates are in research or development and have not received regulatory approval as being safe and effective in any country.
Some of the statements on this website are forward-looking.This includes statements related to Oculis and Oculis’ drug candidates that may express or involve discussions with respect to predictions, expectations, beliefs, opinions, plans, projections, objectives, goals, assumptions or future events or performance. Such statements are not statements of historical facts and are inherently subject to known as well as unknown risks and uncertainties, including scientific, business, economic and financial factors and other factors that may cause actual results, performance or achievements to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements speak only as of the date they are posted to this website.
Oculis does not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.